Despite these limitations, the researchers believe the study confirmed the efficacy and safety of bimekizumab and brodalumab ...

A diet of fruits and vegetables, whole grains, low-fat dairy foods and lean meats, low in salt and sugar, is associated with ...

SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

Phase 1b trial designed to provide key insights into VYN202’s potential across a range of chronic, immune-mediated diseases BRIDGEWATER, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc.

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

STELLENBOSCH, WC - The State of South Africa’s Fathers 2024 report paints a not so good picture of what parenting is like in South Africa.

Biologics are more targeted than other psoriasis treatments. They’re also more expensive, and you take them less frequently. Doctors usually prescribe them for moderate to severe psoriasis.

Patients aged 55 years and older are more likely to discontinue biologic treatment for psoriasis due to adverse events, whereas patients aged 16 to 24 years are more likely to discontinue treatment of ...

Psoriatic arthritis (PsA) is a chronic inflammatory immune-mediated disease that affects approximately 30% of psoriasis patients. In most cases, skin disease clearly precedes the musculoskeletal ...